FDA May Relax Dietary Supplement Warning Label Rules
The FDA is evaluating potential changes to dietary supplement warning label requirements, with pharmacists urged to remain vigilant as regulations may loosen under the current administration.
#Dietary Supplements
3 stories
Peptides sold under the dietary-supplement label sit in one of the more contested regulatory zones in the field. The line between drug claims, structure-function claims, and unapproved drug marketing keeps producing enforcement actions on both sides of the US-Canada border.
Recent threads: Health Canada's public advisory against unauthorized injectable peptides (BPC-157, CJC-1295, retatrutide and others) marketed for weight loss, anti-aging, and bodybuilding; FDA warning letters to peptide vendors making drug claims; and the broader policy debate about what counts as a supplement when the underlying compound is a prescription-grade peptide.
Stories here cover the enforcement actions and the ongoing regulatory line. See #anti-aging and #wellness for related threads.
PBS NewsHour: Dietary Supplement Makers Push FDA to Allow Peptides as New Ingredients
The FDA held a public meeting at the Natural Products Association's request to discuss broadening supplement criteria to include peptides. FDA official Kyle Diamantas emphasized 'cutting red tape' under the Kennedy-era HHS stance.
FDA Holds Historic Meeting on Allowing Peptides as Dietary Supplement Ingredients
The FDA held a public meeting to discuss broadening supplement ingredient criteria to include peptides, probiotics, and other substances. This is the first such meeting since RFK Jr. became HHS Secretary.